Stay updated with the latest greater-china news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on greater-china topics.
Bengaluru : Akamai (NASDAQ: AKAM) announced the appointment of Fiona Zhang as Regional Vice President, Channel Sales and Programs for Asia Pacific and Japan, reinforcing its commitment to a channel-first growth strategy and the critical role partners play in scaling its cloud and security business across the region. In her new role, Fiona will lead Akamai's channel strategy and partner ecosystem across Asia Pacific and Japan, focusing on enabling partners to deliver greater value to customers a ...Read More >
New Delhi [India], April 7: DBS Bank India announced its new DBS Aspire banking proposition, along with the signature Aspire debit card, designed for the country's fast-growing, well-travelled, emerging affluent segment. DBS Aspire extends premium banking access to clients with a total relationship value of Rs. 10 lakh or a minimum monthly savings account average balance of Rs. 2 lakh, positioning the bank as a long-term banking partner to these customers as they grow their wealth. Also Read | ...Read More >
Delhi's Khan Market has slipped to 24th globally in expensive retail locations, though it remains India's priciest high street. London's New Bond Street now leads the world. Indian high streets show remarkable resilience, attracting brands due to rising affluence and limited mall supply, driving significant rental growth in cities like Gurugram and New Delhi. Delhi's upscale Khan Market rank slipped one notch to 24th in a global list of the most expensive high-street retail locations, with an a ...Read More >
Bengaluru - Nike on Sept 30 reported a surprise rise in first-quarter revenue and beat profit expectations as the storied sportswear brand's turnaround effort gained traction despite weakness in China and tariffs pressuring margins. The company also managed to clear some of its bloated inventory and wholesale revenues returned to growth in a sign of early success for chief executive Elliott Hill's plan to get Nike back to its former glory. Executives warned the recovery was still a way off. W ...Read More >
Bengaluru: Global investor Brookfield Asset Management, through its private real estate fund, has sold a 50% stake in Bluegrass Business Park in Pune to 360 ONE Asset for an enterprise value of ₹2,400 crore. The 2 million square feet office development in Pune's Kalyani Nagar locality isspread across 7 acres. Bluegrass Business Park comprises a million sq ft operational tower that is leased to Mastercard, and an under-construction office tower. Brookfield will continue to oversee the management ...Read More >
New Delhi, Jul 11 (PTI) Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to commmercialise its underdevelopment drug aimed to treat cancer and autoimmune diseases in an up to USD 2 billion deal, one of the largest transactions in the pharma sector. The stock surged 9.99 per cent to hit its 52-week high as well as the upper circuit limit of Rs 2,095.65 on the BSE. At the NSE, the stock zoomed 10 per cent to Rs 2,094.40 -- i ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Also Read | Bodoland ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Under the agreement, ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.